Cargando…

In vivo Illustration of Altered Dopaminergic and GABAergic Systems in Early Parkinson's Disease

BACKGROUND: Changes in γ-aminobutyric acid (GABA) function are noted in patients with Parkinson's disease (PD) who have some non-motor impairments. However, dopamine-related GABA function and GABA-related cognitive changes are still unclear. METHODS: Thirteen drug-naive early-stage PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takashima, Hirotsugu, Terada, Tatsuhiro, Bunai, Tomoyasu, Matsudaira, Takashi, Obi, Tomokazu, Ouchi, Yasuomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152017/ https://www.ncbi.nlm.nih.gov/pubmed/35655619 http://dx.doi.org/10.3389/fneur.2022.880407

Ejemplares similares

Coexistence of cerebral hypometabolism and neuroinflammation in the thalamo-limbic-brainstem region in young women with functional somatic syndrome
por: Matsudaira, Takashi, et al.
Publicado: (2020)

Alterations in serotonin transporter and body image-related cognition in anorexia nervosa
por: Yokokura, Masamichi, et al.
Publicado: (2019)

Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer’s disease
por: Terada, Tatsuhiro, et al.
Publicado: (2021)

Toward the Development of tES- Based Telemedicine System: Insights From the Digital Transformation and Neurophysiological Evidence
por: Ikeda, Takashi, et al.
Publicado: (2022)

An altered GABA-A receptor function in spinocerebellar ataxia type 6 and familial hemiplegic migraine type 1 associated with the CACNA1A gene mutation
por: Kono, Satoshi, et al.
Publicado: (2014)

Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: a study with positron emission tomography
por: Fukai, Mina, et al.
Publicado: (2019)

Cognitive Impairment in a Complex Family With AAGGG and ACAGG Repeat Expansions in RFC1 Detected by ExpansionHunter Denovo
por: Watanabe, Kazuki, et al.
Publicado: (2022)

Theory of mind deficits in Parkinson’s disease are not modulated by dopaminergic medication
por: Usnich, Tatiana, et al.
Publicado: (2023)

Dopaminergic Modulation of Sensory Attenuation in Parkinson's Disease: Is There an Underlying Modulation of Beta Power?
por: Macerollo, Antonella, et al.
Publicado: (2019)

KCNQ2 channels regulate the population activity of neonatal GABAergic neurons ex vivo
por: Hou, Bowen, et al.
Publicado: (2023)

Bradykinesia Is Driven by Cumulative Beta Power During Continuous Movement and Alleviated by Gabaergic Modulation in Parkinson's Disease
por: Prokic, Emma J., et al.
Publicado: (2019)

Association Between Dopaminergic Medications and the Evolution of REM Sleep Behavior Disorder in Parkinson's Disease
por: Cao, Ruihua, et al.
Publicado: (2022)

Implications of dopaminergic medication withdrawal in Parkinson’s disease
por: Koschel, J., et al.
Publicado: (2021)

Dopaminergic Treatment Effects on Dysarthric Speech: Acoustic Analysis in a Cohort of Patients With Advanced Parkinson's Disease
por: Cavallieri, Francesco, et al.
Publicado: (2021)

Is Generalized and Segmental Dystonia Accompanied by Impairments in the Dopaminergic System?
por: Ikezawa, Jun, et al.
Publicado: (2021)

Nigrostriatal Dopaminergic Dysfunction and Altered Functional Connectivity in REM Sleep Behavior Disorder With Mild Motor Impairment
por: Yamada, Gohei, et al.
Publicado: (2019)

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies
por: Martini, Alice, et al.
Publicado: (2018)

Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
por: Costas, Carmen, et al.
Publicado: (2022)

GABAergic Gene Regulatory Elements Used in Adeno-Associated Viral Vectors
por: Duba-Kiss, Robert, et al.
Publicado: (2021)

Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson’s Model
por: Lai, Jessica IChi, et al.
Publicado: (2023)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Parietal Perfusion Alterations in Parkinson's Disease Patients Without Dementia
por: Pelizzari, Laura, et al.
Publicado: (2020)

Distribution of GABAergic Interneurons and Dopaminergic Cells in the Functional Territories of the Human Striatum
por: Bernácer, Javier, et al.
Publicado: (2012)

The impact of cathodal tDCS on the GABAergic system in the epileptogenic zone: A multimodal imaging study
por: Abuhaiba, Sulaiman I., et al.
Publicado: (2022)

Zonisamide for the Efficacy of Sleep Abnormality in Parkinson's Disease (ZEAL Study): A Protocol for Randomized Controlled Trials
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Altered Whole-Brain and Network-Based Functional Connectivity in Parkinson's Disease
por: de Schipper, Laura J., et al.
Publicado: (2018)

The Effect of GABAergic Cells Transplantation on Allodynia and Hyperalgesia in Neuropathic Animals: A Systematic Review With Meta-Analysis
por: Zhang, Zhen-Rong, et al.
Publicado: (2022)

Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease
por: Song, Juhyun, et al.
Publicado: (2016)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Cntnap4/Caspr4 Differentially Contributes to GABAergic and Dopaminergic Synaptic Transmission
por: Karayannis, T., et al.
Publicado: (2014)

The Many Faces of Blurry Vision in Parkinson's Disease: An Illustrative Case Series
por: Borm, Carlijn D.J.M., et al.
Publicado: (2022)

Are GABAergic drugs beneficial in providing neuroprotection after traumatic brain injuries? A comprehensive literature review of preclinical studies
por: Sudhakar, Shyam Kumar
Publicado: (2023)

Linking Pathological Oscillations With Altered Temporal Processing in Parkinsons Disease: Neurophysiological Mechanisms and Implications for Neuromodulation
por: Beudel, Martijn, et al.
Publicado: (2019)

White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness
por: Ashraf-Ganjouei, Amir, et al.
Publicado: (2019)

Altered Brain Functional Network in Parkinson Disease With Rapid Eye Movement Sleep Behavior Disorder
por: Li, Jiao, et al.
Publicado: (2020)

Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease
por: Ren, Tengzhu, et al.
Publicado: (2020)

Dynamic Alterations of Spontaneous Neural Activity in Parkinson's Disease: A Resting-State fMRI Study
por: Zhang, Chao, et al.
Publicado: (2019)

Altered Cerebellar Resting-State Functional Connectivity in Early-Stage Parkinson's Disease Patients With Cognitive Impairment
por: Dan, Xiaojuan, et al.
Publicado: (2021)

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease
por: Lozovaya, N., et al.
Publicado: (2018)

Inhibition of Trigeminal Nociception by Non-invasive Vagus Nerve Stimulation: Investigating the Role of GABAergic and Serotonergic Pathways in a Model of Episodic Migraine
por: Cornelison, Lauren E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1u551505s19e8lu03hv5vbnb9h